ZIVALIO-M 500ER Tablets
For better Diabetic Outcome
COMPOSITION: Dapagliflozin 10mg + Metformin HCL IP 500mg Tablets
- Highly potent antihyperglycemic agent, beneficial for the treatment of type 2 diabetes (T2D).
- Outstanding cardioprotective and renoprotective agent, an excellent option for patients with a history of cardiovascular and renal diseases.
- Monotherapy as well as combination therapy provides effective glycaemic control, and reduces body weight and blood pressure (BP) across a broad spectrum of patients.
- Co-administration of dapagliflozin and metformin has a valuable synergistic effect in maintaining blood sugar levels and reduces the incidence of hypoglycemia.
- Highly effective in both early and late stages of T2DM, this helps in stopping the clinical progression of diabetes mellitus.
INDICATIONS:
- Diabetes Mellitus
- Hypoglycemia
- Cardiovascular Disorders
- Renal Diseases
Description
- Highly potent antihyperglycemic agent, beneficial for the treatment of type 2 diabetes (T2D).
- Outstanding cardioprotective and renoprotective agent, an excellent option for patients with a history of cardiovascular and renal diseases.
- Monotherapy as well as combination therapy provides effective glycaemic control, and reduces body weight and blood pressure (BP) across a broad spectrum of patients.
- Co-administration of dapagliflozin and metformin has a valuable synergistic effect in maintaining blood sugar levels and reduces the incidence of hypoglycemia.
- Highly effective in both early and late stages of T2DM, this helps in stopping the clinical progression of diabetes mellitus.
